Achieving therapeutic vancomycin levels in pediatric patients.
暂无分享,去创建一个
[1] E. Capparelli,et al. Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure , 2013, The Pediatric infectious disease journal.
[2] Tsz-Yin So,et al. An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents , 2011, International journal of pediatrics.
[3] L. Benet,et al. Impact of a Hospitalwide Increase in Empiric Pediatric Vancomycin Dosing on Initial Trough Concentrations , 2011, Pharmacotherapy.
[4] Thomas M. English,et al. Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients , 2011, The Annals of pharmacotherapy.
[5] M. Jahng,et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. , 2011, The Journal of pediatrics.
[6] L. Benet,et al. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. , 2010, Clinical therapeutics.
[7] L. Benet,et al. Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate , 2009, The Pediatric infectious disease journal.
[8] A. Wong-Beringer,et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. , 2006, Archives of internal medicine.
[9] J. Wolfsdorf,et al. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. , 2000, Journal of critical care.
[10] T. Johns,et al. Laboratory guidelines for monitoring of antimicrobial drugs , 1998 .
[11] K. Rodvold,et al. Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children , 1997, Clinical pharmacokinetics.
[12] D. Paterson,et al. Milligrams per Liter Maintain Troughs between 15 and 20 Associated with Dosing Schedules That Vancomycin-Induced Nephrotoxicity Systematic Review and Meta-Analysis of , 2013 .
[13] N. Shime,et al. Pharmacokinetics of glycopeptide antibiotics in children , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[14] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Mary A. Worthington,et al. Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review. , 2009, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[16] D. Levine,et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[17] M. Rybak,et al. The pharmacokinetic and pharmacodynamic properties of vancomycin. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Nahata,et al. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants , 2004, European Journal of Clinical Pharmacology.